The generic version of the erectile dysfunction treatment will be available in the US from December 2017.
The US Food and Drug Administration (FDA) has awarded Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) approval for the first-ever generic version of Viagra. The generic version of the erectile dysfunction treatment, known as sildenafil citrate, will be available to the public in the US from December 11 2017.
Teva's generic version will be available in 25, 50 and 100 milligram tablets and the Israeli pharmaceutical company will have 180 days exclusive generic marketing.
Viagra is a branded drug produced and marketed by Pfizer. After protracted patent litigation, in which Pfizer claimed its patent was good until 2020, the two companies came to a compromise agreement in 2013, allowing Teva to market a generic version of the drug from December 2017.
Published by Globes [online], Israel business news - www.globes-online.com - on March 15, 2016
© Copyright of Globes Publisher Itonut (1983) Ltd. 2016
Viagra